中文 | English
Return
Total: 405 , 1/41
Show Home Prev Next End page: GO
Author:( Xuejun LI)

1.Regulation of chromosome regulator EZH2 in cancer epigenetics and EZH2 targeted drugs in cancer therapy

Xin LI ; Xuejun LI

Chinese Journal of Pharmacology and Toxicology 2016;30(12):1273-1281

2.Drug targets discovery based on dynamic signal transduction networks.

Juan WANG ; Xuejun LI

Acta Pharmaceutica Sinica 2010;45(1):1-8

3.Analysis of 15 case with Bartter syndrome and literature review

Xuejun YANG ; Qiu LI

Journal of Clinical Pediatrics 2014;(8):785-788

4.Chemical proteomics and discovery of drug targets.

Hongqin YANG ; Xuejun LI

Acta Pharmaceutica Sinica 2011;46(8):877-82

5.Application of anti-CD20 monoclonal antibody in the treatment of active systemic lupus erythematosus

Jie LI ; Xuejun ZENG

Basic & Clinical Medicine 2006;0(02):-

6.Progress of Early Diagnosis in Primary Carcinoma of Gallbladder

Shoushuai LI ; Xuejun SUN

Chinese Journal of Bases and Clinics in General Surgery 2003;0(04):-

7.Amplification of 160 000 Bullous Pemphigoid Antigen cDNA Fragment from Human Keratinocyte Library

Guanqun LI ; Xuejun ZHU

Chinese Journal of Dermatology 1995;0(03):-

8.Detection of HPV DNA in Condylomata Acuminata by Direct in Situ PCR

Hui LI ; Xuejun ZHU

Chinese Journal of Dermatology 1995;0(03):-

9.Hydroxyl radical and cerebral ischemia

Xuejun LI ; Fengyan SUN

Chinese Pharmacological Bulletin 1998;0(S1):-

10.CT Staging of Gallbladder Carcinoma and Its Role in Evaluation of Surgical Resectability

Xuejun PING ; Chunlin LI

Journal of Practical Radiology 2001;0(10):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 405 , 1/41 Show Home Prev Next End page: GO